Proceedings.

SRx Group of Companies

Follow
Active
Proceeding
CCAACompanies' Creditors Arrangement Act, R.S.C. 1985, c. C-36, as amended
File
CV-25-00749244-00CL
Filings held69
Last activity20 May 2026
On the record396 days
OverviewSummary updated

SRx Group of Companies — SRx Health Solutions (Canada) Inc. and the affiliated entities listed at Schedule A — began CCAA proceedings on August 21, 2025, before the Ontario Superior Court of Justice (Commercial List), with Grant Thornton Limited appointed Monitor. The same day, the court approved a sale under an approval and vesting order and extended the CCAA stay of proceedings. Counsel of record includes Miller Thomson LLP; the court file number is CV-25-00749244-00CL.

Proceedings AIAsk this case — answers cite the filings
Ask in plain language. The answer comes only from this case’s filings, each one cited.
Enter to send · Shift+Enter for a new line
Case updates69 dated entries · 1 undated
#Report

The officer filed report no. Seventh Report. All planned sale transactions in the SRx Group's CCAA sale process have closed and operations have been wound down with no remaining employees; the parent company's CEO continues to assist with remaining distribution matters.

Source: Seventh Report of the Monitor dated May 13, 2026.pdf

#Report

The officer filed report no. Fifth Report. All planned sale transactions in the CCAA Sale Process have been completed and the SRx Group's operations have been wound down with no remaining employees, though the parent company's CEO continues to assist with remaining matters.

Source: Fifth Report of the Monitor dated March 27, 2026.pdf

#Report

The officer filed report no. Third Report. The SRx Group is winding down operations, closing its Ontario warehouse, terminating employees, and working to close remaining Court-approved sale transactions for its pharmacy and clinic locations under the CCAA sale process.

Source: Third Report of the Monitor dated November 25, 2025.pdf

#Sale

The court granted an approval and vesting order for the sale to Ansana BL Inc. Closing terms, as extracted: Vesting effective upon delivery of Monitor's Certificate confirming payment of purchase price, satisfaction/waiver of closing conditions, and completion of the Transaction. Sealed: Sale Agreement attached as Confidential Appendix I to the First Report.

Source: Adesh - Brownsline - AVO.PDF

#Sale

The court granted an approval and vesting order for the sale to ANSANA NEPEAN INC. Closing terms, as extracted: Vesting occurs upon delivery of the Monitor's Certificate confirming payment of Purchase Price, satisfaction/waiver of Closing conditions, and completion of the Transaction. Sealed: Sale Agreement.

Source: Adesh - Nepean - AVO.PDF

#Sale

The court granted an approval and vesting order for the sale to 1001332766 Ontario Inc. Closing terms, as extracted: Vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price, satisfaction of closing conditions under section 7, and completion of the Transaction. Sealed: Sale Agreement.

Source: Cairn Merchant Partners Inc. AVO.PDF

#Order

SRx Group of Companies — CCAA filed, Ontario.

Undated filings1 — no date appears on the document · show
Filing

Service List.DOCX Application filed

PDF

Parties

Debtor

SRx Group of Companies

Monitor

Doane Grant Thornton

Bench and counselPer the orders and service lists on the record

Bench

JudgeCourtOn this docketCases on record
Justice BlackOntario Superior Court of Justice7 orders, Aug 2025 – May 2026176 cases on record
Justice CavanaghOntario Superior Court of Justice2 orders, Nov 2025 – Apr 2026288 cases on record
Justice DietrichOntario Superior Court of Justice2 orders, Mar 202689 cases on record
Justice ConwayOntario Superior Court of Justice2 orders, Jan 2026285 cases on record

Counsel of record

PartyCounselFirst seenSource
DebtorSRx Group of CompaniesMiller Thomson LLP · Millerthomsonllp21 Aug 2025Application · 29 Jan 2026
Capital structureAs asserted in the filings
Priority classCreditorAmountSource
UnsecuredUnsecured creditors (aggregate as reported) · in 532 casesDocument itemises individual creditors on pages 1-13; total shown here reflects the stated grand total. Given the extremely large number of itemised creditors (hundreds), individual entries are not separately reproduced here beyond noting the total; see itemised list on pages 1-13 for names/amounts (e.g. McKesson Canada Corporation $7,960,869; Nu-Quest Distribution Inc. $7,057,562; SRX Health Wholesale & Distribution $35,304,743; Borden Ladner Gervais LLP $1,602,922; Manulife $324,518; Mnp LLP $348,185; DORSEY & WHITNEY LLP $272,851; PURPOSEMED INC $207,242; Shoppers Drug Mart Specialty Health · as of 8 Aug 2025$58.7MCreditor Listing as of August 8, 2025.pdf
Sale processAs stated in the filings

16 transactions · 8 closed · 8 approvedA listing of all locations of the SRx Group that have been acquired by various purchasers within the Sale Process and approved by the CourtSeventh Report of the Monitor dated May 13, 2026.pdf · 13 May 2026

Bid deadline (round closed)

18 August 2025

Sale Process Procedures.pdf

PurchaserPriceStatusSource
1001332766 Ontario Inc.the purchased assets described in the Sale Agreement · asset sale · agreement 21 Aug 2025SealedSale Agreement filed as Confidential Appendix to First Report; price not stated in the order itselfCloseddate not statedMonitor's Certificate (Cairn Transaction) dated…
2725463 Alberta Inc.the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · agreement 21 Aug 2025SealedApproved21 Aug 20252725463 AB Ltd - AVO.PDF
ANSANA BC Inc.All assets acquired for or used exclusively in connection with the operation of the Pharmacy, as defined in the Sale Agreement · asset sale · agreement 21 Aug 2025not statedApproved21 Aug 2025Adesh - Garden Park - AVO.PDF
ANSANA Calgary Inc.the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · agreement 21 Aug 2025not statedApproved21 Aug 2025Adesh - Calgary - AVO.PDF
ANSANA London Inc.the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · agreement 21 Aug 2025SealedApproved21 Aug 2025Adesh - London - AVO.PDF
ANSANA MISS INC.the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · agreement 21 Aug 2025not statedClosed22 Oct 2025Monitor's Certificate (London) dated October…
ANSANA NEPEAN INC.the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · agreement 21 Aug 2025SealedCloseddate not statedMonitor's Certificate (Nepean) dated October…
ANSANA Ottawa Inc.the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · agreement 21 Aug 2025SealedApproved21 Aug 2025Adesh - Ottawa - AVO.PDF
Ansana BL Inc.the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · agreement 21 Aug 2025SealedClosed22 Oct 2025Monitor's Certificate (Brownsline) dated…
Carruthers Drugs Ltd.the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · agreement 21 Aug 2025not statedApproved21 Aug 2025Carruthers Drugs Ltd. - AVO.PDF
Green Room Investments Inc.the charter and articles of incorporation of the Company and the assets and business associated with a pharmacy located at 223 Main Street, Vancouver, British Columbia · share subscription · ResidualCo: 1001333161 Ontario Inc. · agreement 21 Aug 2025SealedClosed4 Nov 2025Monitor's Certificate (Pier Health) dated…
PerCuro Clinical Research Inc.the Purchased Assets described in the Sale Agreement and listed on Schedule C hereto · asset sale · agreement 21 Aug 2025not statedCloseddate not statedMonitor's Certificate (PerCuro Clinical…
PurposeMed Inc.the charter and articles of incorporation of SRx Health Ontario Inc. and the assets and business associated with a specialty pharmacy located at 34 Wellesley Street East, Toronto · share subscription · agreement 21 Aug 2025Sealedthe Monitor has received the balance of the Cash Purchase PriceCloseddate not statedSeventh Report of the Monitor dated May 13,…
1553081 B.C. Ltd.all assets acquired for or used exclusively in connection with the operation of the Pharmacy located at 102-1173 The High Street, Coquitlam, British Columbia, including all Books and Records, Business Intellectual Property (excluding any intellectual property incorporating or consisting of 'SRx' or any derivation thereof), Approvals, fixed assets and goodwill · share sale · agreement 21 Aug 2025not statedApproved29 Oct 2025Approval and Vesting Order on Mediglen of…
2741067 Alberta Ltd.the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · agreement 2 Oct 2025not statedApproved29 Oct 2025Approval and Vesting Order on Edmonton of…
Green Room Investments Inc.the share Subscription Agreement made as of August 20, 2025 · share subscription · agreement 20 Aug 2025not statedthe Monitor has received the balance of the Cash Purchase PriceClosedSeventh Report of the Monitor dated May 13,…
Closing termsVesting effective upon delivery of the Monitor's Certificate confirming payment of purchase price, satisfaction/waiver of closing conditions, and completion of the Transaction.Approval and Vesting Order on Edmonton of Justice Black dated October…
Sealed materialsSale Agreement attached as Confidential Appendix D to the First Report; Sale Agreement; Subscription Agreement; Sale Agreement attached as Confidential Appendix I to the First Report; Sale Agreement attached as Confidential Appendix L to the First Report; Sale Agreement (Confidential Appendix 'M' to First Report)2725463 AB Ltd - AVO.PDF
Fees and ratesAs stated in the filings

1 engagement · 1 firmCozen O'Connor LLP, 1 Oct 2025 – 8 May 2026Seventh Report of the Monitor dated May 13, 2026.pdf · 13 May 2026

FirmPeriodHoursFeesRatesSource
Cozen O'Connor LLPCounsel to the monitor1 Oct 2025 – 8 May 2026$628.02stated averageSeventh Report of the Monitor dated May 13, 2026.pdf · 13 May 2026
Estate financialsReported figures — never derived

Cash on hand

$685K

As at 27 Mar 2026Fifth Report of the Monitor dated March 27, 2026.pdf

Professional fees to date

$357K

As at 13 May 2026Seventh Report of the Monitor dated May 13, 2026.pdf

Documents
69 filings
DateDocumentFile
Endorsement of Justice Black dated May 20, 2026.pdf
  • Presiding officer Justice Black
PDF
Motion Record of the Applicants returnable May 20, 2026.pdfPDF
Order of Justice Black dated May 20, 2026.pdf
  • Presiding officer Justice Black
PDF
Factum of the SRX Group dated May 19, 2026.pdfPDF
Seventh Report of the Monitor dated May 13, 2026.pdf
  • Cash on hand Note: The Monitor states it anticipates sufficient cash on hand but does not give a figure. · Currency: CAD · Qualifier: sufficient
  • Closing confirmed Closed · date not stated · Green Room Investments Inc.; Closed · date not stated · PurposeMed Inc.
  • Fee schedule Engagements: Form: prose · Rows: · Money: Approximate: false · Period: End: 2026-05-08 · Kind: invoice · Label: Statement of Account · Quote: services rendered to the Monitor for the period from October 1, 2025 through May 8, 2026 (the ' Statement of Account ') · Start: 2025-10-01 · Approval: State: unstated · Averages: — · Currency: · Invoices: · Firm text: Cozen O'Connor LLP · Firm quote: I am an Associate with the law firm Cozen O'Connor LLP (" Cozen O'Connor ") · Context quote: Attached hereto as Exhibit 'A' is a true copy of the statement of account of Cozen O'Connor in respect of services rendered to the Monitor for the period from October 1, 2025 through May 8, 2026 (the ' Statement of Account ').
  • Operational summary All planned sale transactions in the SRx Group's CCAA sale process have closed and operations have been wound down with no remaining employees; the parent company's CEO continues to assist with remaining distribution matters.
  • + 5 more extracted facts
PDF
Endorsement of Justice Cavanagh dated April 13, 2026.pdf
  • Presiding officer Justice Cavanagh
PDF
Sixth Report of the Monitor dated April 8, 2026.pdf
  • Operational summary The SRx Group completed an abbreviated sale process resulting in 16 pharmacy/clinic sale transactions; operations have effectively wound down and the CCAA proceedings are now focused on resolving a distribution dispute among the DIP Lender and secured creditors and reviewing a pre-filing transfer to the Parent Company.
  • Process results 15 bids · as of 21 Aug 2025
  • Report no Sixth Report
  • Sale outcome Sale closed — Following completion of the Sale Process, the Court approved fourteen transactions involving various pharmacy and clinic assets.
PDF
Endorsement of Justice J. Dietrich dated March 30, 2026.pdf
  • Presiding officer Justice J. Dietrich
PDF
Motion Record of the Applicants Returnable March 30, 2026.pdfPDF
Stay Extension Order dated March 30, 2026.pdf
  • Presiding officer Justice J. Dietrich
PDF
Fifth Report of the Monitor dated March 27, 2026.pdf
  • Cash on hand $685K · Note: Actual closing cash per Third Extended Cash Flow Forecast variance table as at Week 33, period ending March 27, 2026 · As at: 2026-03-27
  • Operational summary All planned sale transactions in the CCAA Sale Process have been completed and the SRx Group's operations have been wound down with no remaining employees, though the parent company's CEO continues to assist with remaining matters.
  • Professional fees $94.4K · Note: Positive variance vs budget relates to WIP outstanding for Monitor and its counsel; payment anticipated April 2026 · Party: Monitor and its counsel · Period: Weeks 25-33, January 24 to March 27, 2026
  • Report date 27 March 2026
  • + 1 more extracted fact
PDF
Endorsement of Justice Conway dated January 30, 2026.pdf
  • Presiding officer Justice Conway
PDF
Order dated January 30, 2026.pdf
  • Presiding officer Justice Conway
PDF
Fourth Report of the Monitor dated January 29, 2026.pdf
  • Cash on hand $642K · Note: This is a forecasted closing cash balance for Weeks 25-33, not an actual reported cash position. · Qualifier: projected closing cash per Third Extended Cash Flow Forecast
  • Operational summary All planned sale transactions have closed and SRx Group's operations have been wound down, with only one Canadian employee retained on an hourly basis to assist with remaining matters.
  • Professional fees $449K · Note: Approximate figure; lower than forecasted $560,000 for the period. · Party: SRx Group's counsel, Monitor, and Monitor's counsel, collectively · Period: period ending January 23, 2026
  • Report date 29 January 2026
  • + 1 more extracted fact
PDF
Statement of Law dated January 29, 2026.pdf
  • Counsel Miller Thomson LLP
PDF
Monitor's Certificate (Calgary) dated January 7, 2026.pdfPDF
Monitor's Certificate (Mediglen) dated December 19, 2025.pdfPDF
Monitor's Certificate (Garden Park) dated December 1, 2025.pdfPDF
Endorsement of Justice Cavanagh dated November 28, 2025.pdf
  • Presiding officer Justice Cavanagh
PDF
Motion Record returnable November 28, 2025.pdfPDF
Order of Justice Cavanaugh dated November 28, 2025.pdf
  • Presiding officer Justice Cavanaugh
PDF
Third Report of the Monitor dated November 25, 2025.pdf
  • Cash on hand $1.38M · Note: Closing cash per Extended Cash Flow Forecast variance analysis as at Week 15 · As at: 2025-11-21
  • Operational summary The SRx Group is winding down operations, closing its Ontario warehouse, terminating employees, and working to close remaining Court-approved sale transactions for its pharmacy and clinic locations under the CCAA sale process.
  • Professional fees $320K · Note: Approximate figure; excludes DIP-related repayment; payments projected in Second Extended Cash Flow Forecast · Party: Company counsel, Monitor, and Monitor's counsel, collectively · Period: period ending November 21, 2025
  • Purchaser 2741067 Alberta Ltd. · Edmonton Pharmacy · asset sale · approved; 1553081 B.C. Ltd. · Mediglen Pharmacy · share sale · approved
  • + 3 more extracted facts
PDF
Monitor's Certificate (Pier Health) dated November 4, 2025.pdf
  • Closing confirmed Closed · 4 Nov 2025 · Green Room Investments Inc.
PDF
Monitor's Certificate (Edmonton) dated October 31, 2025.pdfPDF
Approval and Vesting Order on Edmonton of Justice Black dated October 29, 2025.pdf
  • Closing terms Vesting effective upon delivery of the Monitor's Certificate confirming payment of purchase price, satisfaction/waiver of closing conditions, and completion of the Transaction.
  • Purchaser 2741067 Alberta Ltd. · the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · approved
  • Sale outcome Sale approved — Transaction approved by the Court
PDF
Approval and Vesting Order on Mediglen of Justice Black dated October 29, 2025.pdf
  • Closing terms Vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price, satisfaction/waiver of closing conditions, and completion of the Transaction.
  • Order date 29 October 2025
  • Purchaser 1553081 B.C. Ltd. · all assets acquired for or used exclusively in connection with the operation of the Pharmacy located at 102-1173 The High Street, Coquitlam, British Columbia, including all Books and Records, Business Intellectual Property (excluding any intellectual property incorporating or consisting of 'SRx' or any derivation thereof), Approvals, fixed assets and goodwill · asset sale · approved
PDF
Endorsement of Justice Black dated October 29, 2025.pdf
  • Presiding officer Justice Black
PDF
Order on Stay Extension of Justice Black dated October 29, 2025.pdf
  • Presiding officer Justice Black
PDF
Second Report of the Monitor dated October 28, 2025.pdfPDF
Monitor's Certificate (CharterCo) dated October 24, 2025.pdfPDF
Monitor's Certificate (Nepean) dated October 24, 2025.pdf
  • Closing confirmed Closed · date not stated · ANSANA Nepean Inc.
PDF
Monitor's Certificate (Nova Scotia) dated October 24, 2025.pdfPDF
Monitor's Certificate (Brownsline) dated October 22, 2025.pdf
  • Closing confirmed Closed · 22 Oct 2025 · Ansana BL Inc.
PDF
Monitor's Certificate (London) dated October 22, 2025.pdf
  • Closing confirmed Closed · 22 Oct 2025 · Ansana Mississauga Inc.
PDF
Monitor's Certificate (Mississauga) dated October 22, 2025.pdfPDF
Monitor's Certificate (Ottawa) dated October 22, 2025.pdfPDF
Monitor's Certificate (Red Deer) dated October 1, 2025.pdfPDF
Monitor's Certificate (Cairn Transaction) dated September 2, 2025.pdf
  • Closing confirmed Closed · date not stated · 1001332766 Ontario Inc.
PDF
Monitor's Certificate (PerCuro Clinical Research Transaction) dated September 2, 2025.pdf
  • Closing confirmed Closed · date not stated · PerCuro Clinical Research Inc.
PDF
15. Amended and Restated Initial Order dated August 21, 2025.pdf
  • Applicant SRX Health Solutions (Canada) Inc. and all of the entities listed at Schedule "A" hereto
  • Appointee Grant Thornton Limited
  • Appointee role monitor
  • Commencement date 21 August 2025
  • + 3 more extracted facts
PDF
2725463 AB Ltd - AVO.PDF
  • Closing terms Vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price, satisfaction/waiver of Closing conditions, and completion of the Transaction
  • Purchaser 2725463 Alberta Inc. · the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · price sealed · approved
  • Sale outcome Sale approved — Transaction approved
  • Sealed items Sale Agreement attached as Confidential Appendix D to the First Report
PDF
Adesh - Brownsline - AVO.PDF
  • Closing terms Vesting effective upon delivery of Monitor's Certificate confirming payment of purchase price, satisfaction/waiver of closing conditions, and completion of the Transaction
  • Order date 21 August 2025
  • Purchaser Ansana BL Inc. · the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · price sealed · approved
  • Sale outcome Sale approved — Transaction approved by the Court
  • + 1 more extracted fact
PDF
Adesh - Calgary - AVO.PDF
  • Closing terms Vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price, satisfaction/waiver of closing conditions, and completion of the Transaction
  • Purchaser ANSANA Calgary Inc. · the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · approved
  • Sale outcome Sale approved — the Transaction is hereby approved
PDF
Adesh - Garden Park - AVO.PDF
  • Closing terms Vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price and satisfaction of closing conditions
  • Purchaser ANSANA BC Inc. · All assets acquired for or used exclusively in connection with the operation of the Pharmacy, as defined in the Sale Agreement · asset sale · approved
PDF
Adesh - London - AVO.PDF
  • Closing terms Vesting occurs upon delivery of the Monitor's Certificate confirming payment of the Purchase Price, satisfaction/waiver of closing conditions under section 7 of the Sale Agreement, and completion of the Transaction.
  • Purchaser ANSANA London Inc. · the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · price sealed · approved
  • Sale outcome Sale approved — Sale transaction approved by the Court
  • Sealed items Sale Agreement attached as Confidential Appendix L to the First Report
PDF
Adesh - Mississauga - AVO.PDF
  • Closing terms Vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price, satisfaction/waiver of Closing conditions, and completion of the Transaction
  • Purchaser ANSANA MISS INC. · the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · approved
PDF
Adesh - Nepean - AVO.PDF
  • Closing terms Vesting occurs upon delivery of the Monitor's Certificate confirming payment of Purchase Price, satisfaction/waiver of Closing conditions, and completion of the Transaction
  • Order date 21 August 2025
  • Purchaser ANSANA NEPEAN INC. · the Vendor's right, title and interest in and to the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · price sealed · approved
  • Sale outcome Sale approved — Transaction approved by court order
  • + 1 more extracted fact
PDF
Adesh - Ottawa - AVO.PDF
  • Closing terms Vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price, satisfaction/waiver of closing conditions, and completion of the Transaction to the Monitor's satisfaction.
  • Purchaser ANSANA Ottawa Inc. · the assets described in the Sale Agreement (the "Purchased Assets") · asset sale · price sealed · approved
  • Sealed items Sale Agreement (Confidential Appendix 'M' to First Report)
PDF
Cairn Merchant Partners Inc. AVO.PDF
  • Closing terms Vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price, satisfaction of closing conditions under section 7, and completion of the Transaction
  • Order date 21 August 2025
  • Purchaser 1001332766 Ontario Inc. · the purchased assets described in the Sale Agreement · asset sale · price sealed · approved
  • Sealed items Sale Agreement
PDF
Carruthers Drugs Ltd. - AVO.PDF
  • Applicant SRx Health Solutions (Canada Inc.) and all of the entities listed at Schedule "A" hereto
  • Appointee Grant Thornton Limited
  • Appointee role Monitor
  • Closing terms vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price, satisfaction/waiver of closing conditions, and completion of Transaction
  • + 7 more extracted facts
PDF
Endorsement of Justice Black dated August 21, 2025.pdf
  • Presiding officer Justice Black
PDF
Factum of the SRX Group (Comeback Hearing) dated August 21, 2025.PDF
  • Counsel Millerthomsonllp
PDF
First Report of the Monitor dated August 21, 2025.pdfPDF
Green Room Investments Inc. - RVO.PDF
  • Closing terms Vesting occurs upon delivery of the Monitor's Certificate at the Effective Time, following a defined sequence of steps including addition of ResidualCo, vesting of Excluded Assets/Liabilities in ResidualCo, and vesting of Purchased Shares in the Purchaser.
  • Order date 21 August 2025
  • Purchaser Green Room Investments Inc. · the charter and articles of incorporation of the Company and the assets and business associated with a pharmacy located at 223 Main Street, Vancouver, British Columbia · share subscription · price sealed · approved
  • Residualco 1001333161 Ontario Inc.
  • + 1 more extracted fact
PDF
Mai Ayoub - AVO.PDF
  • Sale outcome Sale approved — the Transaction is hereby approved
  • Sealed items Sale Agreement
PDF
Motion Record returnable August 21, 2025.PDFPDF
Percuro AVO.PDF
  • Closing terms vesting effective upon delivery of Monitor's Certificate confirming payment of Purchase Price and satisfaction/waiver of Closing conditions
  • Purchaser PerCuro Clinical Research Inc. · the Purchased Assets described in the Sale Agreement and listed on Schedule C hereto · asset sale · approved
  • Sale outcome Sale approved — Transaction is hereby approved
PDF
PurposeMed Inc. - RVO.PDF
  • Closing terms Effective Time upon delivery of the Monitor's Certificate, with a sequence of steps (ResidualCo added as Respondent, Excluded Assets vest in ResidualCo, Excluded Liabilities vest in ResidualCo, Articles of Reorganization filed, Purchased Shares issued to Purchaser, Equity Interests cancelled, Purchased Entities cease being Applicants)
  • Order date 21 August 2025
  • Purchaser PurposeMed Inc. · the charter and articles of incorporation of SRx Health Ontario Inc. and the assets and business associated with a specialty pharmacy located at 34 Wellesley Street East, Toronto · share subscription · price sealed · approved
  • Residualco 1001333162 Ontario Inc.
  • + 2 more extracted facts
PDF
Endorsement of Justice Black dated August 12, 2025.pdf
  • Presiding officer Justice Black
PDF
Initial Order dated August 12, 2025.pdf
  • Applicant SRX HEALTH SOLUTIONS (CANADA) INC. AND ALL OF THE ENTITIES LISTED AT SCHEDULE “A” HERETO
  • Appointee Grant Thornton Limited
  • Appointee role Monitor
  • Court SUPERIOR COURT OF JUSTICE
  • + 3 more extracted facts
PDF
Non-disclosure agreement.pdfPDF
Notice to Creditors of SRx Group CCAA Proceedings.pdfPDF
Pre-Filing Report of the Proposed Monitor dated August 12, 2025.pdfPDF
Sale Process Teaser.pdfPDF
Factum dated August 11, 2025.PDFPDF
Initial Application and Notice of Motion dated August 11, 2025.PDFPDF
Sale Process Procedures.pdf
  • Bid deadline 18 August 2025
PDF
Creditor Listing as of August 8, 2025.pdf
  • Unsecured creditors $58.7M · Note: Document itemises individual creditors on pages 1-13; total shown here reflects the stated grand total. Given the extremely large number of itemised creditors (hundreds), individual entries are not separately reproduced here beyond noting the total; see itemised list on pages 1-13 for names/amounts (e.g. McKesson Canada Corporation $7,960,869; Nu-Quest Distribution Inc. $7,057,562; SRX Health Wholesale & Distribution $35,304,743; Borden Ladner Gervais LLP $1,602,922; Manulife $324,518; Mnp LLP $348,185; DORSEY & WHITNEY LLP $272,851; PURPOSEMED INC $207,242; Shoppers Drug Mart Specialty Health Network Inc. $720,248; NexgenRx $368,790; Grand Concepts Inc. $547,068; Dex Medical Distribution Inc. $425,270; A&D Wholesale Ltd. $235,284; P.A. DRUGS AND MEDICAL LTD. $152,940; MasterControl Solutions, Inc $155,684; Kipling Realty Management Inc. $196,468; Baker Tilly WM LLP $35,533; BDO Canada LLP $16,500; Grant Thornton LLP $12,000; IQVIA Solutions Canada Inc $65,785; and many trade, pharmacy, professional, individual, and utility creditors). · Page: 13 · As of: 2025-08-08 · Basis: Creditor Listing as at August 8, 2025 (Total Creditors) · Debtor: The SRx Group of Companies · Creditor: Unsecured creditors (aggregate as reported)
PDF
Service List.DOCXPDF

Filing titles, dates, and extracted key facts are public.

CiteProceedings., “SRx Group of Companies” (CCAA), Ontario Superior Court of Justice. Retrieved 20 September 2026, https://proceedings.ca/case/srx-group-of-companies

Sources last checked · summary updated 6 September 2026 · Report a correction · Printed from proceedings.ca/case/srx-group-of-companies

Facts and summaries are extracted automatically from the court filings linked on each page; the filings remain the authoritative record. Suggested corrections are reviewed against the source filings.